Approval · Notice of Compliance 10873 · 2009
PREVNAR 13: Notice of Compliance 10873
Issued December 21, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10873
- Date
- December 21, 2009
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREVNAR 13 | 02335204 | Cancelled Post Market |
Medicinal ingredients
- PNEUMOCOCCAL CONJUGATE SEROTYPE 1 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 3 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 4 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 5 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 6A 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 6B 4.4 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 7F 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 9V 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 14 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 19A 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 19F 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 23F 2.2 MCG per 0.5ML
- PNEUMOCOCCAL CONJUGATE SEROTYPE 18C 2.2 MCG per 0.5ML
- CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN 34 MCG per 0.5ML